patentbuddy: Gerhard Siemeister
BAYER PHARMA AKTIENGESELLSCHAFT, Berlin, DE
Angiogenesis in Health and Disease - Taylor & Francis eBookstaylorfrancis.com
www.taylorfrancis.com
— Gerhard Siemeister Research Laboratories o f Schering AG, Berlin, and Institute o f Molecular Medicine, Freiburg, Germany Andreas Menrad — Gerhard Siemeister Research Laboratories o f Schering AG, Berlin, and Institute o f Molecular Medicine, Freiburg, Germany Andreas Menrad ...
A Novel Class of Antiangiogenic VEGF Receptor Kinase ...ACS Publications
pubs.acs.org
von PW Manley · · Zitiert von: 132 — Gerhard Siemeister, and Karl-Heinz Thierauch. Schering AG, Research Laboratories, D , Berlin, Germany. Received April 4, Two readily synthesized ... von PW Manley · · Zitiert von: 132 — Gerhard Siemeister, and Karl-Heinz Thierauch. Schering AG, Research Laboratories, D , Berlin, Germany. Received April 4, Two readily synthesized ...
New Compound 'Highly Efficacious' At Reducing Human ...ScienceDaily
www.sciencedaily.com
— Gerhard Siemeister of Schering AG, Corporate Research, Berlin speaking at the 18th meeting of the European Association of Cancer Research — Gerhard Siemeister of Schering AG, Corporate Research, Berlin speaking at the 18th meeting of the European Association of Cancer Research ...
Tomoregulin Internalization Confers Selective Cytotoxicity of...
www.sciencedirect.com
Affiliations. Department of Experimental Oncology, Schering AG, Berlin, Germany . ,. Gerhard Siemeister. x. Gerhard Siemeister. Search for articles by this author ...
Alle Infos zum Namen "Gerhard Siemeister"
Electronic GazetteIPOPHL
onlineservices.ipophil.gov.ph
GERHARD SIEMEISTER OF BERLIN GERMANY VOLKER SCHULZE OF BERLIN GERMANY HOLGER HESS-TUMPP OF BERLIN GERMANY HANS BRIEM OF BREMEN GERMANY GERHARD SIEMEISTER OF BERLIN GERMANY VOLKER SCHULZE OF BERLIN GERMANY HOLGER HESS-TUMPP OF BERLIN GERMANY HANS BRIEM OF BREMEN GERMANY
Evaluation of activity and combination strategies with the ...VTT's Research Information Portal
cris.vtt.fi
von J Eschenbrenner · · Zitiert von: 10 — ... Gerhard Siemeister, Jens Hoffmann. VTT Technical Research Centre of Finland. Bayer AG; Technical University of Berlin; Freie Universität Berlin; University of ... von J Eschenbrenner · · Zitiert von: 10 — ... Gerhard Siemeister, Jens Hoffmann. VTT Technical Research Centre of Finland. Bayer AG; Technical University of Berlin; Freie Universität Berlin; University of ...
Ohne TitelUnited States Patent and Trademark Office (.gov)
patentsgazette.uspto.gov
Combination of ATR kinase inhibitors with PARP inhibitors ; Antje Margret Wengner, Berlin (DE); and Gerhard Siemeister, Berlin (DE). Combination of ATR kinase inhibitors with PARP inhibitors ; Antje Margret Wengner, Berlin (DE); and Gerhard Siemeister, Berlin (DE).
Probing the catalytic functions of Bub1 kinase using ...eLife
elifesciences.org
von AP Baron · · Zitiert von: 64 — Gerhard Siemeister. Global Drug Discovery, Bayer Pharma AG, Berlin, Germany. Contribution. GS, Conception and design, Analysis and ... von AP Baron · · Zitiert von: 64 — Gerhard Siemeister. Global Drug Discovery, Bayer Pharma AG, Berlin, Germany. Contribution. GS, Conception and design, Analysis and ...
Synergistic Effect of a Mesothelin-Targeted 227 Th ...Europe PMC
europepmc.org
von K Wickstroem · · Zitiert von: 46 — ... Gerhard Siemeister. 2Bayer AG, TRG-Oncology II, Berlin, Germany; and. Find articles by Gerhard Siemeister. Roger M. Bjerke. 1Thorium Conjugate Research, Bayer ... von K Wickstroem · · Zitiert von: 46 — ... Gerhard Siemeister. 2Bayer AG, TRG-Oncology II, Berlin, Germany; and. Find articles by Gerhard Siemeister. Roger M. Bjerke. 1Thorium Conjugate Research, Bayer ...
Inhibition of VEGF Receptor Tyrosine Kinase | Gerhard Siemeister Resea
www.taylorfrancis.com
Gerhard Siemeister Research Laboratories o f Schering AG, Berlin, and Institute o f Molecular Medicine, Freiburg, Germany Andreas Menrad, Michael Schirner, ...
it-app.dziv.hr
Gerhard Siemeister, Reimerswalder Steig 26, Berlin, DE Stefan PrechtlBerlin, DE Ulf Bömer
SULFOXIMINE-SUBSTITUTED ANILINOPYRIMIDINE DERIVATIVES AS CDK...
www.patentsencyclopedia.com
Assignees: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT Patent applications by Gerhard Siemeister, Berlin DE
Use of the Novel Plk1 Inhibitor ZK-Thiazolidinone to Elucidate...
www.ncbi.nlm.nih.gov
... Dominik Mumberg,§ Stefan Prechtl,§ Volker Schulze,§ Gerhard Siemeister,§ ... §Bayer Schering Pharma AG, Global Drug Discovery, Berlin, Germany.
Verwandte Suchanfragen zu Gerhard Siemeister
Philip Lienau Niels Böhnke Benjamin Bader | Dieter Marmé Dennis Wegener Dominik Mumberg | Jens Hoffmann Hanno Glimm Jens Schröder |
Personen Vorname "Gerhard" (38185) Name "Siemeister" (13) |
sortiert nach Relevanz / Datum